New peptide could be effective treatment for triple negative breast cancer
A new peptide developed by researchers in Temple University’s College of Science and Technology has demonstrated efficacy against triple negative breast cancer.
The leptin receptor antagonist peptide, developed by researchers Laszlo Otvos and Eva …